新着情報Information
2024.10.31
DPCデータを用いた臨床研究
私たちの教室では、DPCデータを用いた医療現場における臨床研究を推進しています。
DPC（Diagnosis Procedure Combination）データは、日本全国の医療機関から集められる膨大な診療情報を含んでおり、医療の質の向上やコストの最適化に関する研究に貴重な情報源となります。
私たちの研究では、このデータを活用し、臨床アウトカムの改善、医療提供体制の評価、さらに新たな医療政策の提言など、幅広い視点から社会に貢献することを目指しています。
臨床研究に興味がある方や、データ解析技術を学びたい方は、ぜひ私たちの教室にご参加ください。
ともに、データ駆動型の医療革新を目指しましょう!!
これまでの研究成果
- Encarnacion MRN, Kawai R, Kuwabiraki H, Ban N, Yoshida H, Shintani A, Tsuruta D, Hiroyasu S. Clinical characteristics and outcomes of autoimmune blistering diseases in Japan. J Dermatol. 2024 Oct 26. doi: 10.1111/1346-8138.17518. Epub ahead of print. PMID: 39460506.
- Imanishi Y, Taniuchi S, Kodama S, Yoshida H, Ito T, Kawai R, Okubo N, Shintani A. Real-world fracture risk, osteoporosis treatment status, and mortality of Japanese non-dialysis patients with chronic kidney disease stages G3-5. Clin Exp Nephrol. 2024 Oct 14. doi: 10.1007/s10157-024-02562-y. Epub ahead of print. PMID: 39402308.
- Imoto W, Ihara Y, Imai T, Kawai R, Yamada K, Kaneko Y, Shintani A, Kakeya H. Incidence and risk factors for coronavirus disease 2019-associated pulmonary aspergillosis using administrative claims data. Mycoses. 2024 Aug;67(8):e13773. doi: 10.1111/myc.13773. PMID: 39090076.
- Imoto W, Imai T, Kawai R, Ihara Y, Nonomiya Y, Namikawa H, Yamada K, Yoshida H, Kaneko Y, Shintani A, Kakeya H. Incidence and potential risk factors of human cytomegalovirus infection in patients with severe and critical coronavirus disease 2019. J Infect Chemother. 2024 Jun 27:S1341-321X(24)00171-5. doi: 10.1016/j.jiac.2024.06.015. Epub ahead of print. PMID: 38944381.
- Imoto W, Ihara Y, Imai T, Tamoto M, Ibuki T, Yamada K, Kaneko Y, Shintani A, Kakeya H. Evaluating the association of body mass index with COVID-19 severity and mortality using Japanese administrative claims data. J Infect Chemother. 2024 Oct;30(10):1054-1060. doi: 10.1016/j.jiac.2024.04.007. Epub 2024 Apr 16. PMID: 38636933.
- Shimomura Y, Sawa K, Imai T, Ihara Y, Yoshida H, Shintani A. Treatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer. Cancer Sci. 2024 Mar;115(3):926-936. doi: 10.1111/cas.16056. Epub 2023 Dec 27. PMID: 38148717; PMCID: PMC10920989.
- Sawa K, Ihara Y, Imai T, Sugimoto A, Nagamine H, Ogawa K, Nakahama K, Matsumoto Y, Tani Y, Kaneda H, Mitsuoka S, Kawaguchi T, Shintani A. Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study. Clin Lung Cancer. 2024 Mar;25(2):144-150.e3. doi: 10.1016/j.cllc.2023.11.003. Epub 2023 Nov 7. PMID: 38042690.
- Ihara Y, Sawa K, Imai T, Kimura T, Otani M, Kawai R, Takatori S, Shintani A. Renin-angiotensin-aldosterone system inhibitors are associated with improved paclitaxel-induced peripheral neuropathy in lung cancer: a study using administrative claims data. Support Care Cancer. 2023 Nov 29;31(12):730. doi: 10.1007/s00520-023-08193-5. PMID: 38019339.
- Yokoyama H, Araki SI, Yamazaki K, Kawai K, Shirabe SI, Oishi M, Kanatsuka A, Yagi N, Kabata D, Shintani A, Maegawa H; JDDM study group. Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66). BMJ Open Diabetes Res Care. 2022 May;10(3):e002727. doi: 10.1136/bmjdrc-2021-002727. PMID: 35504696; PMCID: PMC9066475.